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A B S T R A C T
The article deals with physical exercise in the early prevention of metabolic syndrome, which is one of the most fre-
quent diseases today. Sedentary life style of modern man, surrounded by sophisticated technological achievements, su-
persedes the time spent in motion in all age groups, from the earliest childhood. The growing number of well substanti-
ated studies has yielded results connecting such kind of life with greater incidence of many chronic diseases and low
functional capability of an organism. Metabolic syndrome (MS) is a complex process and one of the most important
groups of diseases, presenting a major health problem in developing countries. MS is an increasing risk for coronary
heart disease, stroke and peripheral angiopathy. MS comprises overweight and abdominal (intraperitoneal) apple shape
obesity, insulin resistance or glucose intolerance (type 2 diabetes mellitus – some persons are genetically predisposed to
insulin resistance), hypertriglyceridemia with low HDL and high LDL cholesterol, accompanied by arterial hyperten-
sion. The prevention of metabolic syndrome should start as early as possible. Regarding physical activity, the period of
childhood and adolescence is very important from the aspects of public health. However, intervention exercise programs
should not be limited to younger age groups, but must encompass all age groups within population.
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Introduction
Physical activity is markedly reduced in professional
work, in going to and returning from job, as well as in
performing home chores for the majority of adults today.
Heavy physical work in developed countries recedes in
front of mechanization and robotics. The time spent sit-
ting in front of a TV or video becomes longer, as well as
the time spent playing video games, sitting in a car, surf-
ing on the Internet, while going shopping, to banks or
elsewhere becomes rarer. The number of persons whose
life can be described as sedentary has never been so
large. A growing number of well substantiated studies
have yielded results connecting such kind of life with
greater incidence of many chronic diseases and low func-
tional capability of an organism1–8. Having in mind the
generally accepted fact that chronic metabolic and car-
diovascular diseases have their source early, in childhood
and adolescence, particularly concerning is the increas-
ing prevalence of inactivity during adolescence.
Physical Activity
The level of everyday activity varies according to gen-
der, age and a series of other factors9. The level is higher
in boys than in girls of the same chronological age 10.
Boys spend more time in moderate and intense activities
than their female peers. Factors associated with the ev-
eryday activity level of preschool children are gender, his-
tory of preterm birth, childcare centers and the father’s
body mass index (BMI)10. The investigations of the Euro-
pean and North American school children and adolescents
have shown that the activity of a school child rises till the
early adolescent period, when it starts to decrease. The
children’s activity significantly decreases during adoles-
cence, what is attributed to biological, environmental and
social impacts11,12. The decrease is especially pronounced
in the late adolescent phase, particularly in young men
who are otherwise more active than girls throughout the
whole period of growth and development13. The Dutch
study by Kemper et al.14 showed that during adolescence
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the decrease is quite observable in the time spent in mod-
erate and high intensity activities, with observably more
time devoted to mild intensity activities. Sedentary life
style of modern man, surrounded by sophisticated tech-
nological achievements, supersedes the time spent in
physical activity from the earliest childhood15.
Metabolic Syndrome
Metabolic syndrome (MS) or syndromes such as syn-
drome X plus, insulin resistance syndrome, obesity syn-
drome, diabesity, metabolic three-syndrome, big four,
quartet of death, plurimetabolic syndrome, or Reaven’s
syndrome (GM Reaven described ot in 1988)16,17 is a com-
plex process and in our time one of the most important
group of diseases and a major health problem in develop-
ing countries. MS is an increasing risk for coronary heart
disease, stroke and peripheral arteriopathy18–20. MS con-
sists of overweight and abdominal (intraperitoneal) apple
shape obesity, insulin resistance or glucose intolerance
(type 2 diabetes mellitus – some persons are genetically
predisposed to insulin resistance), hypertriglyceridemia
with low HDL and high LDL cholesterol accompanied by
arterial hypertension. It is associated with prothrombo-
tic state with high serum fibrinogen or plasminogen acti-
vator inhibitor-1 level, endothelial dysfunction and a
pro-inflammatory state with the high level of C-reactive
protein in the serum21. An assemblage of risk factors for
MS includes age, obesity, history of diabetes mellitus and
other similar diseases such as polycistic ovarian syn-
drome with metabolic consequences in women, hormones
and reproductive system etc22.
Definitions of the metabolic syndrome
The World Health Organization (WHO) definition23,24
requires that individual with MS have: 1) hyperglycaemia/
insulin resistance or fasting glucose level 6.1 mmol/L
and at least two of the following criteria: 2) abdominal or
central obesity and WHR (waist to hip ratio) >0.90 in
men and >0.85 in women and/or BMI >30 kg/m2; 3) se-
rum triglyceride level 1.69 mmol/L and/or HDL choles-
terol <0.9 mmol/L in males and <1.00 mmol/L in fe-
males; 4) high blood pressure 140/90 mmHg or treat-
ment with drugs; 5) microalbuminuria: urinary albumin
excretion rate 20 mg/min or urinary albumin/creatinine
ratio >3.5 mg/mmol.
The criteria of the National Institute of Health (Third
Report of the National Cholesterol Education Program or
NECP, Evaluation, and Treatment of High Blood Choles-
terol in Adults, Adult Treatment Panel III or ATP III)25
does not explicitly include insulin resistence of glucose
intolerance as required criteria, rather defines the MS as
the co-occurence of three or more of the following five
criteria: 1) abdominal obesity-waist circumference >102
cm in men, >88 cm in women; 2) hyperglycaemia: fasting
plasma glucose 6.1 mmol/L or treatment with antidia-
betics; 3) serum triglyceride level >1.69 mmol/L or drug
treatment; 4) HDL cholesterol <1.04 mmol/L in men,
<1.29 mmol/L in women or drug treatment; 5) high
blood pressure 130 mmHg systolic and 85 mmHg dia-
stolic or drug(s) treatment.
The criteria of the American Heart Association (AHA)
and The National Heart, Lung and Blood Institute26,27
(NHLBI) include: 1) waist circumference the same as
ATP III (does not include BMI) and at least two of the fol-
lowing criteria: 2) fasting glucose 5.6 mmol/L; 3) serum
triglycerides the same as WHO; 4) serum HDL choles-
terol the same as NCEP/ATP III; 5) blood pressure the
same as NCEP/ATP III.
The criteria of the European group for the study of the
insulin resistance28 (EGIR) includes insulin resistance
with 2 of the following: fasting plasma glucose level 6.1
mmol/L without diabetes mellitus; increased waist cir-
cumference 94 cm for males and 80 cm for females;
triglyceride levels 2.0 mmol/L or treatment for elevated
triglycerides level, and/or HDL cholesterol levels <1.0
mmol/L or treatment for reduced HDL cholesterol levels;
blood pressure 140/90 mmHg or treatment for arterial
hypertension.
The criteria of the International Diabetes Federation
(IDF)29–31 include: 1) central obesity, i.e. waist circumfer-
ence in Mediterraneans: 94 cm in males, 80 cm in fe-
males, and at least two of the following criteria: 2) fast-
ing plasma glucose level the same as in ATP III or
therapy for type 2 diabetes mellitus; 3) serum triglycer-
ides 1.7 mmol/L or therapy for triglyceridemia; and/or
4) HDL-cholesterol level <1.00 mmol/L in males and
<1.30 in females; 5) blood pressure as in ATP III and
AHA/NHLBI or therapy with antihypertensives.
The criteria of the International Diabetes Federation
(IDF) in adolescents (10-16 years)32,33 requires the follow-
ing: 1) central obesity measured by waist circumference
90 percentile for child,s age, and at least two of the fol-
lowing criteria: 2) glucose level 5.6 mmol/L, glucose in-
tolerance; 3) serum triglyceride level 1.7 mmol/L; 4)
HDL-cholesterol level <1.03 mmol/L; 5) blood pressure
130 or 85 mmHg (Table 1). According to IDF31, it is not
possible to diagnose metabolic syndrome in children <10
years. However, in children with abdominal obesity and
risk factors: positive family history of MS, type 2 diabetes
mellitus, obesity, hyperlipoproteinemia, cardiovascular
diseases including arterial hypertension, further obser-
vations and preventive measures have do be done, pri-
marily for weight reduction.
In the study of Hirschler33 out of 167 children, 11.3%
had the metabolic syndrome and 21.9% among over-
weight children. Ford and co-workers34 have reported the
prevalence of 24% in adult U.S. population aged 20 yrs,
increasing from 6.7% among the participants aged 20
through 29 years to 43.5% and 42.0% for the participants
aged 60 through 69 years and aged at least 70 years, re-
spectively. In 2004, Ford et al.35 reported an increase in
MS prevalence in U.S. adults aged 20 yrs from 24% in
NHANES III25 to 27% in NHANES 1990–200024. Similar
prevalence is reported for some European popula-
tions18,36,37. Bokor et al.38 have revealed the high preva-
lence of MS among obese European children and adoles-
cents. Recently, a modification of the metabolic syndrome
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criteria designed for children and adolescents shows that
50 percent of U.S. children who are severely overweight
have MS39.
Physical Exercise in the Prevention of
Metabolic Syndrome
The group of known risk factors for the development
of chronic metabolic and cardiovascular diseases with
high incidence in modern populations (e.g. atherosclero-
sis, metabolic syndrome, coronary heart disease, diabetes
mellitus, arterial hypertension) comprises obesity, in-
creased fats in blood, elevated arterial blood pressure, low
sensitivity to insulin, physical inactivity, cigarette smok-
ing, and in the last two decades the identified group of
risk factors for the development of coronary heart dis-
ease (CHD), including factors as fibrinogen, homocys-
teine, C-reactive protein, plasminogen activator inhibitor
1 and endothelial dysfunction. In the prevention of chro-
nic diseases, we are particularly interested in factors
which can be already treated in the early age. A signifi-
cant number of young people present at least one risk
factor for the development of coronary heart diseases.
With the increase of risk factors rises also the individual
risk for chronic diseases of the heart and blood ves-
sels40,41. Here we must ask ourselves whether an early
start of physical exercise prevents the occurrence of some
cited risk factors for certain diseases. Parizkova42 in her
lecture in 1996, at the annual meeting of the just estab-
lished European Association of Sport Sciences stated,
that »…a genotype characterized by a high level of spon-
taneous body activity has a significantly higher HDL-C,
with the trend of larger body dimensions, less fat reserve,
higher energy input by food, higher cardiorespiratory
and motor abilities, what is observable already in the
pre-school age«41. The effect of physical exercise in child-
hood and adolescence upon health in adult age can be
viewed through: directly observable benefit, the influ-
ence on the child’s health and the impact upon the level
of physical activity in adulthood43 – or, more precisely, ac-
cording to Blair et al.44, through possible connection be-
tween physical activity during childhood and adolescence
and health in adult age: 1) the connection of physical ac-
tivity and health in young age; 2) the connection of physi-
cal activity during young age and physical activity in
adulthood; and 3) the connection of physical activity dur-
ing young age and health in adult age.
The investigations of Wilmore40 long ago have con-
firmed that from the early school age we find in children
the factors for the development of CHD. The prevalence
of obesity increases with school age. Obesity, along with
reduced physical activity, will develop in the case of inad-
equately high energy intake through food in relation to
actual energy expenditure45. A significant link between
obesity and hours spent in front of a TV has been con-
firmed in the sample of American children46,47. Seden-
tary habits are also related to increased intake of addi-
tional snacks47. The majority of studies base the
estimation of overweight and obesity only upon the mea-
sures of body mass and height, mostly by using body
mass index. In children, for the definition of overweight
and obesity are used respective cutoff points of the 85.
and 95. percentile of referent BMI values for a particular
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TABLE 1
CRITERIA OF METABOLIC SYNDROME
Adults Adolescents
Clinical and WHO23,24 NCEP AHA/ EGIR28 IDF29-31 IDF32,33
biochemical ATP III25 NHLBI26,27
parameters
Waist – 102 m 102 m 94 m 94 m 90th
circumference 88 f 88 f 80 f 80 f percentile
(cm)
Waist to hip >0.90 m – – – – –
ratio (WHR) >0.85 f – – – – –
Glucose 6.1 6.1 5.6 6.1 5.6 5.6
(mmol/L)
Insulin
resistance yes no no yes no no
Body mass index
(BMI kg/m2) >30 – – – – –
Triglycerides 1.69 1.69 1.69 2.0 1.7 1.7
(mmol/L)
HDL-
cholesterol <0.90 m <1.04 m <1.04 m <1.0 <1.03 m <1.03
(mmol/L) <1.00 f <1.29 f <1.29 f <1.0 <1.30 f
Blood pressure 140/90 130/85 130/85 140/90 130/85 130/85
(mmHg)
age48,49. Nowadays, the estimations are more and more
based on the body composition analysis, the portion of
body fat and its distribution50–57. In a five-year period we
have registered the trend of changes in the body compo-
sition in Croatian preschool children with the increase of
body fat portion, without changes in BMI, along with the
substantial reduction of non-fat mass portion in girls,
particularly on the account of muscle mass in upper
extremities58. The causes of such changes we have
sought in nutritional habits and physical exercise. In
population of Croatian school children, overweight is
present in about 11% of children aged 7–14 yrs, and
among them 5.2% are obese59.
It need not be particularly stressed that obesity jeop-
ardizes health and is connected with the early onset of a
series of diseases, as coronary heart disease, arterial hy-
pertension, diabetes mellitus, hyperlipoproteinemia, liver
diseases and some malignant diseases more frequently
occurring in obese people. Obesity endangers health and
negatively impacts the ability of mastering motor tasks.
According to Vanhala et al.60, obesity in adult age is more
harmful for health if it lasts since childhood. Fat tissue
(particularly its visceral component) is not only »ballast«
mass but hormonally extremely active tissue61. Many fac-
tors secreted in adipose tissue participate in the patho-
genesis of metabolic diseases. Thus, the excessive accu-
mulation of fat tissue is regarded as an independent
metabolic risk60. The body fat accumulation of the cen-
tral abdominal type (android or apple-like type) is a sub-
stantially greater metabolic risk than other types of body
fat accumulation (gynoid or pear-like, and intermediary
type). Thus, today the measures of waist circumference
and the ratio of waist and hip circumference are consid-
ered to be important predictors of metabolic risk and risk
for some chronic diseases, independent from overweight
estimated by the body mass index. Visceral fat is a strong
predictor of insulin resistance and glucose intolerance. It
is related to the increased level of triglycerides and de-
creased level of high-density lipoproteins (HDL-choles-
terol)61.
Physical exercise plays an important role in the body
mass regulation and in the prevention of obesity in chil-
dren and adults4,5,7,8,42,62–64. It influences both sides of en-
ergy balance. Physical exercise is considered as one of the
key links between hormonal modulators of energy meta-
bolism5. Sympathetic nervous system and catecholamine
affecting adipose metabolism directly and through the
impact on hormones influencing the fat metabolism play
the major role in enhancing the lipolysis during exer-
cise5. The amount of fat oxidized during exercise and
post-exercise period depends on a number of factors. The
type of exercise, its intensity and duration, energy expen-
diture during exercise, gender and individual fitness
level are some of the factors influencing the amount of
oxidized fat8.
A number of studies show lower levels of arterial
blood pressure and other cardiovascular risk factors in
children with better functional capacities65–68. The study
by Boreham et al.67 has showed that in 15-yr-old boys
physical activity was beneficially associated with systolic
blood pressure, lipid profile, and cardiorespiratory fit-
ness. In 15-yr-old girls, sport participation was benefi-
cially associated with fatness and cardiorespiratory fit-
ness. Obese children often have higher levels of blood
pressure. Examining the independence of the relation-
ship between the cardiovascular risk factors and both
body fatness and cardiorespiratory fitness in adolescents,
Boreham et al.67 have revealed that the relationships be-
tween fitness and cardiovascular risk status in adoles-
cents are mediated by fatness. Similar results have been
recently shown by Tomas et al.69. The results stress the
importance of early prevention of overweight and obe-
sity.
Many studies of the correlation of activity levels or
cardiovascular fitness and risk factors for the develop-
ment of coronary heart disease in the young have con-
firmed significant positive correlation between HDL-C
level and aerobic endurance, as well as higher HDL-C
level and lower triglyceride level in active children70–72. A
certain number of studies have investigated the possible
correlation of cardiovascular disease risk factors, such as
homocysteine, fibrinogen, C-reactive protein, plasmino-
gen activator inhibitor I, thrombin-antithrombin com-
plex and endothelial function with the level of physical
activity in children and adolescents73–75. More thorough
research of this phenomenon is still expected.
In children, the type of relationship and levels of min-
imal daily physical activity indispensable for the preven-
tion of risk factors for chronic metabolic and cardiovas-
cular diseases are less known than in adults. Speaking
about adults, there is a consensus on general recommen-
dations for minimal duration, frequency and intensity of
physical activity aimed at health protection and preven-
tion of chronic diseases76,77, as well as special recommen-
dations for the prevention and treatment of obesity62,63.
For school children, the attitudes are not homogenous.
For the purpose of health protection, the majority argue
for the minimum of 60 minutes of moderate to intense
activity daily, adjusted to age. It develops cardiovascular
endurance and muscle strength, simultaneously includes
»carrying one’s own body mass« (what contributes to
bone density)78, and diminishes the time of sedentary
daily activities in front of the TV, PC, video games, tele-
phone etc. Canadian authors recommend increase in the
daily amount of physical activity for another 30 minu-
tes79. Anderson et al.80 consider the recommended mini-
mum of 60 minutes insufficient and suggest more activi-
ties, but varied according to age. Approach based on rec-
ommendations for restricting time spent in sedentary
activities is not simple and requires change in numerous
environmental factors which will facilitate more safe and
free motion of children and adolescents62.
Thus, health protection and primary prevention of
obesity and metabolic syndrome, the syndrome of grow-
ing prevalence, should be started as early as possible
with special attention paid to adoption of correct nutri-
tional habits and physical activities from preschool to
school age. It is important to include parents in encour-
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aging and directing a child to activities, along with the
crucial role of school through physical education, which
is needed daily, and further promotion of school sports,
restriction of time the children spend sitting at school
daily and weekly, as well as by prolonging breaks during
which children may practice physical activities. Ensuring
safe moving of children in everyday comings to and
goings from school on foot or on bikes, as well as avail-
ability of equipped and safe playgrounds, will enable in-
creased level of physical activity during free time.
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TJELESNO VJE@BANJE U RANOJ PREVENCIJI METABOLI^KOG SINDROMA
S A @ E T A K
Metaboli~ki sindrom jedna je od naj~e{}ih bolesti danas. Sjede}i na~in `ivljenja moderna ~ovjeka okru`enog sofisti-
ciranim tehnolo{kim pomagalima ve} u ranoj dje~joj dobi pretpostavlja se kretanju. Na~in `ivljenja, prema mnogim
istra`ivanjima, povezan je s pove}anom incidencijom kroni~nih bolesti i smanjenju funkcijske sposobnosti. Metaboli~ki
sindrom (MS) naj~e{}a je skupina bolesti, napose u zemljama u razvoju. To je uslo`eno zbivanje u kojem je pove}ana
opasnost za razvoj koronarne bolesti srca, mo`dane kapi i periferne angiopatije. MS uklju~uje pove}anu tjelesnu masu,
abdominalni ili jabukoliki (intraperitonealni) tip pretilosti, rezistenciju na inzulin ili netoleranciju glukoze (tip 2 {e}er-
ne bolesti – neke su osobe genetski predodre|ene za rezistenciju prema inzulinu), hipertrigliceridemiju, s niskom kon-
centracijom serumskog lipoproteina visoke gusto}e (HDL), povi{enom koncentracijom lipoproteina niske gusto}e (LDL) i
povi{enim arterijskim krvnim tlakom. U ~lanku su izneseni postupci tjelesnog vje`banja u ranoj prevenciji tog sindro-
ma. Njegova prevencija treba po~eti {to je ranije mogu}e. Glede tjelovje`be, period ranog djetinjstva i adolescentne dobi
vrlo su va`ni sa stanovi{ta javnog zdravstva. Me|utim, postupci intervencijskog tjelovje`benog programa ne trebaju biti
vezani samo za skupinu mla|e dobi, ve} trebaju obuhva}ati sve dobne skupine stanovni{tva.
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